cystic
fibrosi
cf
common
inherit
disord
affect
varieti
epitheli
tissu
diseas
caus
mutat
cystic
fibrosi
transmembran
conduct
regul
gene
cftr
lead
abnorm
secret
recurr
infect
inflamm
bronchiectasi
prematur
death
airway
diseas
major
caus
morbid
mortal
cystic
fibrosi
gene
therapi
effort
focus
lumin
deliveri
vector
airway
cf
patient
retrovirus
attract
gene
transfer
vector
system
sinc
integr
wildtyp
cftr
cdna
host
genom
may
lead
longterm
express
perhap
cure
howev
simpl
retrovirus
limit
vector
airway
gene
transfer
low
rate
epitheli
cell
prolifer
human
airway
combin
tradit
low
titer
advanc
vector
design
product
improv
titer
develop
human
anim
lentivirus
may
help
overcom
requir
cell
prolifer
develop
rais
hope
retrovir
approach
treatment
cf
lung
diseas
bestknown
lentivirus
human
immunodefici
virus
type
simian
immunodefici
virus
siv
hiv
felin
immunodefici
viru
fiv
equin
infecti
anemia
viru
eiav
develop
gene
transfer
vector
cystic
fibrosi
lentivir
vector
shown
transduc
varieti
nondivid
cell
type
vitro
vivo
hiv
eiav
fiv
vector
shown
effici
transduc
aphidicolintr
growtharrest
airway
epitheli
cell
vitro
envelop
protein
lentivir
vector
bind
cell
surfac
receptor
facilit
entri
subsequ
revers
transcript
nuclear
import
integr
host
chromosom
culmin
gene
express
evalu
polar
lentivir
transduct
vescicular
stomat
viru
glycoprot
vsvg
pseudotyp
vector
appli
either
apic
basolater
surfac
polar
welldifferenti
wd
human
airway
epitheli
hae
cell
thirtyfold
greater
transduct
effici
observ
vitro
hiv
vsvg
vector
appli
basolater
surfac
compar
apic
applic
vector
goldman
colleagu
demonstr
lumin
appli
hiv
vsvg
vector
fail
transduc
wd
primari
hae
cell
bronchial
xenograft
similar
data
evolv
eiav
pseudotyp
vsvg
amphotropicand
vsvgenvelop
fiv
vector
data
suggest
lentivir
vector
transduc
nondivid
cell
receptor
uptak
entri
amphotrop
vsvg
pseudotyp
mlv
lentivir
vector
predominantli
local
basolater
membran
polar
epitheli
cell
two
strategi
propos
overcom
lack
apic
membran
receptor
express
host
modif
injuri
model
agent
permeabil
tight
junction
increas
vector
access
basolater
membran
receptor
basal
cell
target
apic
membran
polar
airway
epithelia
pseudotyp
lentivirus
envelop
protein
virus
bind
enter
across
apic
membran
injuri
model
transient
permeabil
intercellular
junction
method
host
cell
modifi
increas
access
basolater
receptor
johnson
et
al
expos
mice
sulfur
dioxid
inhal
increas
vector
deliveri
basolater
surfac
andor
basal
cell
murin
trachea
induct
airway
cell
prolifer
peak
h
postinhal
signific
increas
prolifer
occur
first
h
inhal
also
caus
doserel
denud
surfac
epithelium
leav
basal
cell
layer
intact
region
less
sever
injur
permeabl
increas
tight
junction
use
model
mice
expos
h
ppm
hiv
vsvg
vector
deliv
onto
nasal
tracheal
epithelia
rodent
effici
report
gene
transfer
observ
nasal
tracheal
airway
epithelia
wherea
gene
transfer
detect
nasal
tracheal
airway
epithelia
sham
air
expos
control
gene
transfer
murin
trachea
also
effici
follow
exposur
vector
administ
day
exposur
cell
transduc
cell
prolifer
increas
compar
day
inhal
transduct
cell
time
peak
airway
cell
prolifer
occur
find
consist
preferenti
transduct
nondivid
cell
data
demonstr
hiv
vector
effici
transduc
airway
epithelia
vivo
access
receptor
basolater
membran
increas
injuri
transient
permeabil
tight
junction
anoth
method
increas
vector
deliveri
basolater
membran
basal
cell
nonprim
lentivir
vector
coadminist
calcium
chelat
airway
increas
vector
access
basolater
receptor
presum
modul
paracellular
permeabl
wang
subsequ
investig
demonstr
rel
effici
transduct
ciliat
noncili
cell
within
rabbit
airway
vivo
compris
approx
airway
cell
infect
vector
decreas
approx
cell
wk
mechan
attenu
transgen
express
evalu
nevertheless
fivcftr
vector
offer
promis
vector
gene
therapi
cystic
fibrosi
olsen
colleagu
develop
mammalian
lentivir
vector
base
eiav
compar
eiav
much
simpler
genom
hors
infect
wildtyp
eiav
viru
typic
surviv
infect
wildtyp
eiav
replic
human
cell
olsen
demonstr
effici
transduct
wd
primari
hae
cell
apic
applic
eiav
vsvg
galactosidas
lacz
vector
presenc
ethylenediaminetetraacet
acid
edta
egta
increas
access
basolater
receptor
permeabil
tight
junction
persist
transgen
express
vitro
last
posttransduct
longest
period
test
preliminari
studi
eiav
vector
intern
promot
shown
express
report
gene
murin
tracheal
airway
epithelia
follow
injuri
increas
deliveri
basal
cell
basolater
membran
effici
transduct
doserel
minim
transduct
vector
titer
infecti
unit
iu
ml
wherea
vector
approx
iuml
yield
transduct
effici
significantli
greater
observ
lower
eiav
lentivir
titer
target
lentivir
vector
receptor
apic
membran
altern
strategi
increas
airway
gene
transfer
usual
paradigm
retrovir
target
gener
pseudotyp
envelop
protein
virus
target
specif
cell
type
toward
goal
investig
screen
envelop
virus
abil
infect
wd
hae
cell
apic
surfac
although
effort
focus
common
respiratori
virus
other
also
includ
nonrespiratori
virus
respiratori
virus
consid
candid
pseudotyp
respiratori
syncyti
viru
rsv
human
corona
viru
influenza
viru
receiv
attent
wildtyp
replicationcompet
recombin
rsv
shown
infect
enter
cell
across
apic
membran
wd
hae
cell
human
corona
viru
also
shown
bind
enter
across
apic
membran
wd
hae
cell
howev
success
lentivir
pseudotyp
deriv
env
protein
respiratori
virus
report
influenza
viru
subtyp
shown
preferenti
infect
apic
rather
basolater
membran
polar
wd
hae
cell
wherea
apic
infect
hae
cell
subtyp
ineffici
bind
subtyp
appear
specif
sialic
acid
residu
suggest
sialic
acid
residu
may
serv
apic
membran
receptor
target
lentivir
pseudotyp
recent
mors
et
al
shown
preliminari
studi
coexpress
influenza
neuramin
acid
na
protein
produc
cell
enhanc
titer
influenza
hemagglutinin
pseudotyp
eiav
vector
moreov
chimer
pseudotyp
vector
transduc
polar
wd
hae
cell
follow
lumin
applic
env
protein
virus
also
consid
preliminari
studi
fivbas
vector
pseudotyp
amphotrop
xenotrop
vsvg
ecotrop
gibbon
ape
leukemia
viru
galv
marburg
ebola
envelop
glycoprotein
transient
transfect
techniqu
kobing
colleagu
explor
potenti
famili
virus
known
filovirida
target
apic
membran
airway
epithelia
filovirida
envelop
nonseg
neg
sens
rna
virus
includ
ebola
viru
marburg
viru
among
member
identifi
viral
envelop
capabl
mediat
apic
transduct
polar
airliquid
interfac
cultur
hiv
vector
pseudotyp
murin
leukemia
viru
mlv
influenzahemagglutinin
rsv
f
g
protein
mokola
ebola
reston
ebor
ebola
zair
eboz
envelop
concentr
stock
eboz
ebor
pseudotyp
effici
transduc
polar
hae
cell
follow
apic
applic
gene
transfer
cell
compar
cell
follow
basolater
transduct
ebozpseudotyp
hiv
vector
also
transduc
wd
hae
cell
xenograft
freshli
excis
human
tracheal
explant
thu
lentivir
vector
may
overcom
limit
low
rate
cellular
prolifer
pseudotyp
lentivir
vector
specif
envelop
protein
may
overcom
barrier
titer
lack
apic
membran
receptor
polar
wd
hae
cell
previous
publish
method
retrovir
infect
primari
hae
cell
plastic
function
character
cftr
function
vitro
chapter
focu
method
lentivir
transduct
polar
welldifferenti
primari
human
airway
epithelia
vitro
eiav
vector
pseudotyp
vsvg
serv
prototyp
vector
method
written
howev
method
also
applic
hiv
vsvg
pseudotyp
lentivir
vector
enhanc
lumin
gene
transfer
describ
host
modif
approach
shown
use
least
one
current
employ
vsvg
pseudotyp
lentivir
vector
studi
airway
gener
use
capo
mediat
transfect
gener
viru
transient
transfect
make
reagent
although
occas
use
calcium
phosphat
transfect
system
life
technolog
carlsbad
ca
good
result
lhc
basal
media
biofluid
rockvil
md
supplement
hormon
growth
factor
tabl
penicillin
uml
streptomycin
gentamicin
amphotericin
b
ad
antibiot
airliquid
interfac
ali
medium
prepar
mixtur
lhc
basal
medium
dmemh
add
growth
factor
hormon
use
growth
medium
reduc
epiderm
growth
factor
egf
concentr
reduc
ngml
omit
amphotericin
b
gentamicin
filtersteril
eiav
vector
effici
produc
threeplasmid
transfect
cell
similar
vector
product
system
discuss
volum
recent
develop
eiav
packag
cell
line
use
packag
cell
line
cell
line
modifi
express
gagpol
rev
protein
eiav
vsvg
envelop
glycoprotein
cell
use
produc
eiav
lentivir
vector
singl
plasmid
transfect
gene
transfer
vector
method
follow
altern
stabli
modifi
gene
transfer
vector
creat
fullfledg
vector
produc
cell
line
cell
deriv
subclon
human
embryon
kidney
cell
line
two
step
first
stabl
transfect
cell
helper
plasmid
result
follow
recip
plate
procedur
modifi
chang
volumesquant
proport
scaleup
scaledown
note
express
eiav
viral
protein
cell
induc
doxycyclin
sodium
butyr
sodium
butyr
treatment
also
result
increas
vector
yield
cell
omiss
sodium
butyr
result
reduc
vector
titer
add
dnacacl
mixtur
dropwis
bubbl
air
solut
time
ml
pipet
tip
altern
bubbl
air
ml
pipet
addit
incub
mixtur
min
room
temperatur
remov
medium
cell
replac
ml
fresh
medium
add
sampl
cell
dropwis
swirl
plate
gentli
mix
incub
overnight
humidifi
incub
co
next
day
remov
medium
add
ml
fresh
growth
medium
per
plate
contain
mm
sodium
butyr
per
plate
induct
vsvg
express
cell
includ
doxycyclin
incub
h
humidifi
incub
co
next
day
swirl
plate
gentli
remov
cell
supernat
contain
viru
filter
viru
syring
filter
contain
cellulos
acet
polyethersulfon
pe
membran
store
viru
aliquot
larg
batch
ml
ml
remov
larg
cell
debri
centrifug
min
prior
filtrat
corn
pe
membran
filter
system
fisher
scientif
pittsburgh
pa
ml
ml
desir
second
harvest
vector
collect
case
add
ml
fresh
growth
medium
without
sodium
butyr
cultur
dish
includ
doxycyclin
use
cell
incub
h
humidifi
incub
co
harvest
viru
describ
step
advantag
concentr
lentivirus
low
speed
centrifug
provid
gentl
altern
ultracentrifug
result
loss
certain
labil
envelop
glycoprotein
use
approach
success
concentr
eiav
vector
pseudotyp
vsvg
murin
amphotrop
jaagsiekt
sheep
retroviru
influenza
hemagglutinin
ha
envelop
follow
protocol
use
beckman
sw
rotor
use
conic
shape
beckman
brand
konic
tube
ml
capac
pellet
viru
adapt
use
rotor
tube
use
protocol
possibl
process
ml
viruscontain
medium
larger
volum
ml
l
sorval
newton
ct
rotor
use
success
polar
wd
primari
hae
cell
resist
lumin
transduct
vsvg
pseudotyp
amphotrop
envelop
galv
pseudotyp
vector
method
increas
access
vector
basolater
surfac
receptor
appear
express
higher
densiti
appear
increas
gene
transfer
effici
follow
lumin
applic
vector
sever
techniqu
develop
enhanc
gene
transfer
includ
basolater
infect
injuri
pipet
tip
modul
paracellular
permeabl
model
permit
investig
assess
abil
infect
apic
basolater
surfac
cultur
pipet
use
scratch
epitheli
surfac
transduct
vector
preferenti
transduc
basolater
surfac
occur
along
line
injuri
expos
basolater
surfac
uninjur
area
epithelium
calcium
chelat
agent
medium
chain
fatti
acid
shown
enhanc
gene
transfer
polar
airway
epithelia
mediat
ad
adenovirusassoci
vector
aav
lentivir
vector
chelat
agent
egta
edta
effect
lentivir
vector
egta
routin
use
pretreat
coadministr
vector
describ
strategi
egtaor
edtamedi
enhanc
lentivir
vector
gene
transfer
prudent
make
sever
hepe
stock
ph
ph
test
function
collagenco
plastic
tissu
cultur
dish
prepar
follow
dilut
steril
concentr
purifi
collagen
steril
h
appli
mlwell
cultur
plate
mlwell
cultur
plate
mlwell
plate
incub
h
overnight
remov
collagen
aspir
air
dri
tissu
cultur
hood
uv
steril
tissu
cultur
hood
min
seal
plate
parafilm
store
wk
prepar
bpe
stock
howev
bpe
also
purchas
commerci
clonet
san
diego
ca
thaw
matur
unprocess
bovin
pituitari
pel
freez
roger
az
drain
blood
rins
pituitari
chill
pb
add
g
tissu
ml
cold
pb
minc
hamiltonbeach
washington
nc
blender
min
transfer
blend
solut
ml
beckman
centrifug
canist
beckman
rotor
centrifug
min
combin
supernat
aliquot
use
respin
aliquot
min
pass
supernat
filter
prepar
growth
medium
similar
commerci
product
avail
begm
clonet
san
diego
ca
cultur
airway
epitheli
cell
lung
cystic
fibrosi
subject
addit
antibiot
requir
cell
cell
higher
vector
yield
obtain
polyllysineco
plate
use
transfect
attribut
better
adher
cell
plate
medium
chang
use
human
tissu
gener
requir
approv
local
institut
review
board
irb
protect
human
subject
although
use
may
exempt
review
recommend
investig
submit
protocol
review
exempt
appropri
grant
irb
epitheli
cell
yield
greater
h
proteas
digest
h
without
signific
loss
viabil
h
proteas
digest
cell
viabil
decreas
significantli
commerci
avail
permeabl
substrat
use
cultur
polar
hae
cell
includ
millipor
filter
bedford
transwellclear
corn
costar
evom
electrod
steril
use
soak
ethanol
equilibr
ali
medium
prior
use
measur
made
tissu
cultur
hood
room
temperatur
measur
resist
across
blank
tcol
record
subtract
blank
resist
measur
resist
across
hae
cell
tcol
multipli
surfac
area
gener
actual
r
cultur
fulli
differenti
epitheli
sheet
tight
junction
polar
hae
cell
r
ohmscm
typic
cell
higher
resist
cell
investig
appli
hypoton
ca
free
solut
mm
hepe
ph
contain
egta
edta
lumin
bath
bilater
applic
egta
edta
lead
rapid
fall
resist
within
minut
howev
epithelium
may
lift
substrat
chelat
left
basolater
surfac
long
